Gsk Plc Stock Market Value
| GLAXF Stock | USD 31.20 0.04 0.13% |
| Symbol | GSK |
GSK Plc 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to GSK Plc's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of GSK Plc.
| 11/24/2025 |
| 02/22/2026 |
If you would invest 0.00 in GSK Plc on November 24, 2025 and sell it all today you would earn a total of 0.00 from holding GSK plc or generate 0.0% return on investment in GSK Plc over 90 days. GSK Plc is related to or competes with Chugai Pharmaceutical, Sanofi, Chugai Pharmaceutical, CSL, Daiichi Sankyo, MERCK Kommanditgesells, and Merck KGaA. GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of ... More
GSK Plc Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure GSK Plc's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess GSK plc upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.44 | |||
| Information Ratio | 0.1341 | |||
| Maximum Drawdown | 14.84 | |||
| Value At Risk | (6.66) | |||
| Potential Upside | 6.17 |
GSK Plc Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for GSK Plc's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as GSK Plc's standard deviation. In reality, there are many statistical measures that can use GSK Plc historical prices to predict the future GSK Plc's volatility.| Risk Adjusted Performance | 0.1281 | |||
| Jensen Alpha | 0.5498 | |||
| Total Risk Alpha | 0.2123 | |||
| Sortino Ratio | 0.1028 | |||
| Treynor Ratio | (1.63) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of GSK Plc's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
GSK Plc February 22, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1281 | |||
| Market Risk Adjusted Performance | (1.62) | |||
| Mean Deviation | 2.37 | |||
| Semi Deviation | 3.32 | |||
| Downside Deviation | 4.44 | |||
| Coefficient Of Variation | 633.73 | |||
| Standard Deviation | 3.4 | |||
| Variance | 11.58 | |||
| Information Ratio | 0.1341 | |||
| Jensen Alpha | 0.5498 | |||
| Total Risk Alpha | 0.2123 | |||
| Sortino Ratio | 0.1028 | |||
| Treynor Ratio | (1.63) | |||
| Maximum Drawdown | 14.84 | |||
| Value At Risk | (6.66) | |||
| Potential Upside | 6.17 | |||
| Downside Variance | 19.73 | |||
| Semi Variance | 11.02 | |||
| Expected Short fall | (2.46) | |||
| Skewness | (0.39) | |||
| Kurtosis | 0.6498 |
GSK plc Backtested Returns
GSK Plc appears to be not too volatile, given 3 months investment horizon. GSK plc holds Efficiency (Sharpe) Ratio of 0.15, which attests that the entity had a 0.15 % return per unit of risk over the last 3 months. By analyzing GSK Plc's technical indicators, you can evaluate if the expected return of 0.51% is justified by implied risk. Please utilize GSK Plc's Semi Deviation of 3.32, risk adjusted performance of 0.1281, and Market Risk Adjusted Performance of (1.62) to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, GSK Plc holds a performance score of 11. The company retains a Market Volatility (i.e., Beta) of -0.32, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning GSK Plc are expected to decrease at a much lower rate. During the bear market, GSK Plc is likely to outperform the market. Please check GSK Plc's total risk alpha, expected short fall, relative strength index, as well as the relationship between the value at risk and day median price , to make a quick decision on whether GSK Plc's current trending patterns will revert.
Auto-correlation | 0.19 |
Very weak predictability
GSK plc has very weak predictability. Overlapping area represents the amount of predictability between GSK Plc time series from 24th of November 2025 to 8th of January 2026 and 8th of January 2026 to 22nd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of GSK plc price movement. The serial correlation of 0.19 indicates that over 19.0% of current GSK Plc price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.19 | |
| Spearman Rank Test | 0.01 | |
| Residual Average | 0.0 | |
| Price Variance | 6.05 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in GSK Pink Sheet
GSK Plc financial ratios help investors to determine whether GSK Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GSK with respect to the benefits of owning GSK Plc security.